228 related articles for article (PubMed ID: 31266828)
21. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
23. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
[TBL] [Abstract][Full Text] [Related]
24. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
Li X; Wan X; Chen H; Yang S; Liu Y; Mo W; Meng D; Du W; Huang Y; Wu H; Wang J; Li T; Li Y
Clin Cancer Res; 2014 May; 20(9):2312-25. PubMed ID: 24610824
[TBL] [Abstract][Full Text] [Related]
25. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines.
Theodore SC; Rhim JS; Turner T; Yates C
Ethn Dis; 2010; 20(1 Suppl 1):S1-96-100. PubMed ID: 20521394
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
[TBL] [Abstract][Full Text] [Related]
27. Age-related racial disparities in prostate cancer patients: A systematic review.
He T; Mullins CD
Ethn Health; 2017 Apr; 22(2):184-195. PubMed ID: 27706949
[TBL] [Abstract][Full Text] [Related]
28. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
Kittles RA; Baffoe-Bonnie AB; Moses TY; Robbins CM; Ahaghotu C; Huusko P; Pettaway C; Vijayakumar S; Bennett J; Hoke G; Mason T; Weinrich S; Trent JM; Collins FS; Mousses S; Bailey-Wilson J; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD
J Med Genet; 2006 Jun; 43(6):507-11. PubMed ID: 16155194
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
30. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
Caire AA; Sun L; Polascik TJ; Albala DM; Moul JW
BJU Int; 2010 Oct; 106(8):1157-60. PubMed ID: 20367635
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.
Ali HEA; Lung PY; Sholl AB; Gad SA; Bustamante JJ; Ali HI; Rhim JS; Deep G; Zhang J; Abd Elmageed ZY
Sci Rep; 2018 Nov; 8(1):16335. PubMed ID: 30397274
[TBL] [Abstract][Full Text] [Related]
32. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
Majid S; Dar AA; Saini S; Arora S; Shahryari V; Zaman MS; Chang I; Yamamura S; Tanaka Y; Deng G; Dahiya R
Cancer Res; 2012 Dec; 72(24):6435-46. PubMed ID: 23074286
[TBL] [Abstract][Full Text] [Related]
33. Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer.
Thatai LC; Banerjee M; Lai Z; Vaishampayan U
Urology; 2004 Oct; 64(4):738-43. PubMed ID: 15491712
[TBL] [Abstract][Full Text] [Related]
34. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
[TBL] [Abstract][Full Text] [Related]
35. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
[TBL] [Abstract][Full Text] [Related]
36. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
Ramakrishnan S; Cortes-Gomez E; Athans SR; Attwood KM; Rosario SR; Kim SJ; Mager DE; Isenhart EG; Hu Q; Wang J; Woloszynska A
Genome Med; 2024 Apr; 16(1):52. PubMed ID: 38566104
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2.
Hirono T; Jingushi K; Nagata T; Sato M; Minami K; Aoki M; Takeda AH; Umehara T; Egawa H; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Yamamoto M; Shinsato Y; Kawahara K; Furukawa T; Tsujikawa K
Sci Rep; 2019 May; 9(1):6956. PubMed ID: 31061410
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.
Sheng X; Chen H; Wang H; Ding Z; Xu G; Zhang J; Lu W; Wu T; Zhao L
Biomed Pharmacother; 2015 Dec; 76():121-6. PubMed ID: 26653558
[TBL] [Abstract][Full Text] [Related]
39. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
40. Racial Disparity in Localized Prostate Cancer Mortality.
Xin H
J Natl Med Assoc; 2017 Summer; 109(2):86-92. PubMed ID: 28599761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
